Versant Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Versant Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.4K	Sell	90 -106	-54%	-$30.1K	﹤0.01%	1784
2026 Q1	$54.6K	Buy	196 +134	+216%	+$38.6K	0.01%	1183
2025 Q4	$18.8K	Buy	62 +32	+107%	+$9.98K	﹤0.01%	1682
2025 Q3	$8.41K	Buy	+30	New	+$8.16K	﹤0.01%	2012
2025 Q1	–	Sell	-9	Closed	-$2.96K	–	2525
2024 Q4	$2.96K	Buy	+9	New	+$3.06K	﹤0.01%	1962
2024 Q3	–	Sell	-11	Closed	-$3K	–	2016
2024 Q2	$3K	Buy	11 +7	+175%	+$2.04K	﹤0.01%	1384
2024 Q1	$1.38K	Hold	4	–	–	﹤0.01%	1460
2023 Q4	$1.29K	Sell	4 -8	-67%	-$2.51K	﹤0.01%	1428
2023 Q3	$4.3K	Buy	12 +9	+300%	+$3.47K	﹤0.01%	1034
2023 Q2	$1.14K	Sell	3 -14	-82%	-$5.7K	﹤0.01%	1554
2023 Q1	$8.14K	Sell	17 -9	-35%	-$4.21K	﹤0.01%	774
2022 Q4	$10.9K	Buy	26 +14	+117%	+$5.65K	﹤0.01%	644
2022 Q3	$5K	Buy	+12	New	+$5.98K	﹤0.01%	824
2022 Q1	–	Sell	-4	Closed	-$3K	–	1459
2021 Q4	$3K	Hold	4	–	–	﹤0.01%	1013
2021 Q3	$3K	Buy	+4	New	+$3K	﹤0.01%	1013
2019 Q2	–	Sell	-5	Closed	-$1K	–	1415
2019 Q1	$1K	Hold	5	–	–	﹤0.01%	1420
2018 Q4	$1K	Hold	5	–	–	﹤0.01%	1334
2018 Q3	$1K	Hold	5	–	–	﹤0.01%	1386
2018 Q2	$1K	Hold	5	–	–	﹤0.01%	1367
2018 Q1	$1K	Hold	5	–	–	﹤0.01%	1354
2017 Q4	$1K	Hold	5	–	–	﹤0.01%	1399
2017 Q3	$1K	Hold	5	–	–	﹤0.01%	1315
2017 Q2	$1K	Hold	5	–	–	﹤0.01%	1305
2017 Q1	$0	Hold	5	–	–	﹤0.01%	1436
2016 Q4	$0	Hold	5	–	–	﹤0.01%	1390
2016 Q3	$0	Hold	5	–	–	﹤0.01%	1377
2016 Q2	$0	Hold	5	–	–	﹤0.01%	1341
2016 Q1	$0	Hold	5	–	–	﹤0.01%	1336
2015 Q4	$0	Buy	+5	New	+$693	﹤0.01%	1340

Other funds holding BIO

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Versant Capital Management's BIO Position: Q2 2026 in Review

Versant Capital Management reduced its Bio-Rad Laboratories Class A (BIO) stake by 54% in Q2 2026, selling an estimated $30.1K and leaving 90 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1784.

Versant Capital Management first reported a position in BIO in Q4 2015 and has held it in 29 quarters since. The position peaked at $54.6K in Q1 2026. 64 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Versant Capital Management held 90 shares of Bio-Rad Laboratories Class A worth $26.4K as of Q2 2026.
Versant Capital Management sold 106 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $30.1K.
Bio-Rad Laboratories Class A made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1784 holding.
Versant Capital Management first reported a position in Bio-Rad Laboratories Class A in Q4 2015 and has held it in 29 quarters since.
Versant Capital Management's Bio-Rad Laboratories Class A position peaked at $54.6K in Q1 2026.
64 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.